La Jolla Pharmaceutical Co. (LJPC)

8.45
NASDAQ : Health Technology
Prev Close 8.69
Day Low/High 8.39 / 8.80
52 Wk Low/High 5.01 / 18.04
Avg Volume 325.60K
Exchange NASDAQ
Shares Outstanding 27.14M
Market Cap 235.86M
EPS -7.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

La Jolla Pharmaceutical Company Announces Financial Results For The Three And Six Months Ended June 30, 2019 And Highlights Recent Corporate Progress

La Jolla Pharmaceutical Company Announces Financial Results For The Three And Six Months Ended June 30, 2019 And Highlights Recent Corporate Progress

SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from...

La Jolla Pharmaceutical Company Receives Orphan Designation From FDA For LJPC-0118 (Artesunate) For The Treatment Of Malaria

La Jolla Pharmaceutical Company Receives Orphan Designation From FDA For LJPC-0118 (Artesunate) For The Treatment Of Malaria

-Orphan Drug Designation Program offers potentially up to seven years of marketing exclusivity- -NDA Submission Planned for Fourth Quarter of 2019- SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in...

LJPC Makes Bullish Cross Above Critical Moving Average

LJPC Makes Bullish Cross Above Critical Moving Average

In trading on Friday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $11.55, changing hands as high as $13.90 per share.

First Week Of LJPC May 17th Options Trading

First Week Of LJPC May 17th Options Trading

Investors in La Jolla Pharmaceutical Co. saw new options begin trading this week, for the May 17th expiration.

La Jolla Pharmaceutical Becomes Oversold (LJPC)

La Jolla Pharmaceutical Becomes Oversold (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting LJPC Put And Call Options For September 20th

Interesting LJPC Put And Call Options For September 20th

Investors in La Jolla Pharmaceutical Co. saw new options begin trading this week, for the September 20th expiration.

La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections

La Jolla Stock Plummets 44% After Disappointing Drug Sales Projections

La Jolla Pharmaceutical Co.'s share price fell to $5.88 by 1:42 pm, down from its close of $10.52 on Friday, after the company said it expects sales of low blood pressure drug Giapreza to hit $24-$28 million in 2019, roughly half of what analysts had projected.

Relative Strength Alert For La Jolla Pharmaceutical

Relative Strength Alert For La Jolla Pharmaceutical

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LJPC: Insiders Vs. Shorts

LJPC: Insiders Vs. Shorts

The most recent short interest data was recently released for the 11/15/2018 settlement date, and La Jolla Pharmaceutical Co. is one of the most shorted stocks of the Russell 3000, based on 26.03 "days to cover" versus the median component at 4.41.

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Becomes Oversold (LJPC)

La Jolla Pharmaceutical Becomes Oversold (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

La Jolla Pharmaceutical Enters Oversold Territory (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of LJPC October 19th Options Trading

First Week Of LJPC October 19th Options Trading

Investors in La Jolla Pharmaceutical Co. saw new options begin trading this week, for the October 19th expiration.

La Jolla Pharmaceutical Is Now Oversold (LJPC)

La Jolla Pharmaceutical Is Now Oversold (LJPC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical Breaks Above 200-Day Moving Average - Bullish For LJPC

La Jolla Pharmaceutical Breaks Above 200-Day Moving Average - Bullish For LJPC

In trading on Friday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $31.77, changing hands as high as $32.33 per share.

La Jolla Pharmaceutical Enters Oversold Territory

La Jolla Pharmaceutical Enters Oversold Territory

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

In trading on Wednesday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $32.10, changing hands as high as $32.32 per share.

Interesting LJPC Put And Call Options For May 18th

Interesting LJPC Put And Call Options For May 18th

Investors in La Jolla Pharmaceutical Co. saw new options become available this week, for the May 18th expiration.

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

La Jolla Pharmaceutical (LJPC) Shares Cross Above 200 DMA

In trading on Thursday, shares of La Jolla Pharmaceutical Co. crossed above their 200 day moving average of $32.07, changing hands as high as $32.68 per share.

GIAPREZA™ (angiotensin II) Significantly Improved Survival Of Patients With High APACHE II Scores In ATHOS-3 Study

GIAPREZA™ (angiotensin II) Significantly Improved Survival Of Patients With High APACHE II Scores In ATHOS-3 Study

Analysis to Be Presented in Oral Session at the Society of Critical Care Medicine's 47th Critical Care Congress

First Week of LJPC February 16th Options Trading

First Week of LJPC February 16th Options Trading

Investors in La Jolla Pharmaceutical Co. saw new options become available this week, for the February 16th expiration.

TheStreet Quant Rating: D- (Sell)